SUMITOMO PHARMA CO LTD - stock earnings
4506.T Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 13, 2024 BeforeMarket | - / -323.9900000000 | - | - / 79.2 million | - |
4506.T Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -197.3 billion JPY | 79.5 billion JPY |
| 2023Q4 | -50.0 billion JPY | 82.4 billion JPY |
| 2023Q3 | -28.9 billion JPY | 77.0 billion JPY |
| 2023Q2 | -38.9 billion JPY | 75.7 billion JPY |
| 2022Q4 | -11.2 billion JPY | 141.0 billion JPY |
| 2022Q3 | -38.4 billion JPY | 159.4 billion JPY |
| 2022Q2 | 31.1 billion JPY | 159.9 billion JPY |
4506.T Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -315.0 billion JPY | 314.6 billion JPY |
| 2023 | -74.5 billion JPY | 555.5 billion JPY |
| 2022 | 56.4 billion JPY | 560.0 billion JPY |
| 2021 | 56.2 billion JPY | 516.0 billion JPY |
| 2020 | 40.8 billion JPY | 482.7 billion JPY |
4506.T
Price: ¥336
Forward Dividend Yield: 4.17%
Payout Ratio: -3.20%
Dividend Per Share: 14.00 JPY
Earnings Per Share: -792.79 JPY
P/E Ratio: -0.82
Exchange: JPX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 149.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 24
DGR3: -8.33%
DGR5: 17.49%
DGR10: 12.13%
DGR20: 10.99%